Largest biotech companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
CG Oncology has the lowest figure of the 24 biotech companies ranked by cash on hand, at TRY 1.6B, followed by Adaptive Biotechnologies (TRY 3.6B) and ImmunityBio (TRY 4.5B). Figures as of 19 Nov 2026, 00:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- CG OncologyTRY 1.6B
- Median
- TRY 21.8B
- Combined market value
- TRY 42.2T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Cash on hand ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CG OncologyCGON · Health Care | TRY 1.6B | TRY 360.5B | TRY 4,035.82 | 1.34% up | 85% up | ||
| 2 | Adaptive BiotechnologiesADPT · Health Care | TRY 3.6B | TRY 232.4B | TRY 1,435.74 | 0.11% down | 88% up | ||
| 3 | ImmunityBioIBRX · Health Care | TRY 4.5B | TRY 359.6B | TRY 338.00 | 7.03% up | 193% up | ||
| 4 | Halozyme TherapeuticsHALO · Health Care | TRY 6.8B | TRY 551B | TRY 4,832.89 | 0.18% down | 37% up | ||
| 5 | VaxcytePCVX · Health Care | TRY 8.8B | TRY 467.3B | TRY 2,952.20 | 1.48% down | 22% up | ||
| 6 | Twist BioscienceTWST · Health Care | TRY 9.2B | TRY 400.2B | TRY 5,869.59 | 3.88% up | 340% up | ||
| 7 | Kodiak SciencesKOD · Health Care | TRY 10.6B | TRY 322.7B | TRY 4,934.29 | 1.04% up | 396% up | ||
| 8 | Bio-TechneTECH · Health Care | TRY 13.4B | TRY 576.5B | TRY 3,670.07 | 0.17% up | 26% up | ||
| 9 | Scholar Rock HoldingSRRK · Health Care | TRY 16.3B | TRY 295.4B | TRY 2,421.49 | 6.48% up | 14% up | ||
| 10 | CRISPR TherapeuticsCRSP · Health Care | TRY 17.5B | TRY 196.7B | TRY 2,027.49 | 0.10% up | 21% down | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | TRY 18B | TRY 521.7B | TRY 6,110.73 | 0.32% down | 87% up | ||
| 12 | Revolution MedicinesRVMD · Health Care | TRY 19.4B | TRY 1.74T | TRY 8,062.55 | 1.76% down | 131% up | ||
| 13 | ExelixisEXEL · Health Care | TRY 24.3B | TRY 840.6B | TRY 3,445.07 | 0.31% down | 63% up | ||
| 14 | Krystal BiotechKRYS · Health Care | TRY 25B | TRY 471.4B | TRY 15,908.18 | 5.62% up | 46% up | ||
| 15 | RepligenRGEN · Health Care | TRY 28.6B | TRY 556.8B | TRY 8,710.80 | 6.47% up | 5% up | ||
| 16 | Neurocrine BiosciencesNBIX · Health Care | TRY 36B | TRY 831.6B | TRY 8,215.91 | 1.84% down | 20% up | ||
| 17 | QiagenQGEN · Health Care | TRY 42.3B | TRY 516.3B | TRY 2,500.19 | 0.38% down | 12% up | ||
| 18 | ImmunovantIMVT · Health Care | TRY 45.5B | TRY 346.3B | TRY 1,673.35 | 0.12% down | 43% up | ||
| 19 | ModernaMRNA · Health Care | TRY 130.9B | TRY 4.02T | TRY 9,927.60 | 4.84% down | 755% up | ||
| 20 | BiogenBIIB · Health Care | TRY 151.8B | TRY 1.87T | TRY 12,683.06 | 0.25% up | 49% up | ||
| 21 | argenxARGX · Health Care | TRY 176.1B | TRY 2.99T | TRY 47,483.90 | 0.66% down | 4% up | ||
| 22 | Gilead SciencesGILD · Health Care | TRY 381.6B | TRY 10.57T | TRY 8,524.65 | 0.75% down | 33% up | ||
| 23 | BioNTechBNTX · Health Care | TRY 429.6B | TRY 1.04T | TRY 4,200.28 | 1.89% down | 16% down | ||
| 24 | AmgenAMGN · Health Care | TRY 460.5B | TRY 12.11T | TRY 22,393.23 | 3.07% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4477 TRY).
Questions and answers
Which biotech companies have the lowest cash on hand?
CG Oncology (TRY 1.6B), Adaptive Biotechnologies (TRY 3.6B) and ImmunityBio (TRY 4.5B) have the lowest cash on hand of the 24 biotech companies ranked here as of 19 Nov 2026, 00:16 UTC.
How many biotech companies are in this ranking?
24 are ranked by cash on hand.
What are these biotech companies worth together?
The 24 biotech companies ranked by cash on hand have a combined market value of TRY 42.2T as of 19 Nov 2026, 00:16 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.